As part of Sanofi Genzyme's commitment to supporting optimal patient care and sustainable health care systems globally, we recognize the importance of fully understanding the needs of the patient communities we serve. We've learned that one of the best ways to accomplish this is by working with patient organizations, who are closely connected to patients' most important concerns and interests.
While partnering with these organizations has long been fundamental to Sanofi Genzyme's culture and approach, in 2001 we established our internal Patient Advocacy group to formalize our collaborations with the advocacy community. Championing the patient perspective within Sanofi Genzyme, this team works with rare disease organizations to advocate for access to therapies and foster a sense of community among patients and their families. The Patient Advocacy group develops programs to support advocacy group leaders and disseminates critical disease and health care educational information.
With the launch of our MS franchise, Sanofi Genzyme established a fully dedicated MS Advocacy team focused on supporting the needs of the patient community. This team supports critical research and broad registry initiatives, in addition to educational and awareness programs in local to global markets.
Sanofi Genzyme also provides financial support to patient organizations in the form of grants, which are administered in close compliance with all relevant regulations, to help fund the organizations' events, outreach efforts, and other activities.